メベンダゾールのグローバル及び中国市場インサイト・予測(~2027年)

QYResearchが発行した調査報告書(QY21CN4207)
◆英語タイトル:Global and China Mebendazole Market Insights, Forecast to 2027
◆商品コード:QY21CN4207
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年7月1日(※2024年版があります。お問い合わせください。)
◆ページ数:135
◆レポート形式:英語 / PDF
◆納品方法:Eメール(24時間以内)
◆調査対象地域:グローバル、中国
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートではグローバルにおけるメベンダゾールの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、メベンダゾールの種類別市場規模(錠剤、経口懸濁液)、用途別市場規模(2歳以下、2歳以上)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のメベンダゾール市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるメベンダゾールの種類別市場規模(2016年-2027年):錠剤、経口懸濁液
・世界におけるメベンダゾールの用途別市場規模(2016年-2027年):2歳以下、2歳以上
・メベンダゾールの中国市場分析
- メベンダゾールの中国市場規模(2016年-2027年)
- 中国におけるメベンダゾールの主要プレイヤー別市場シェア
- 中国におけるメベンダゾールの種類別市場規模:錠剤、経口懸濁液
- 中国におけるメベンダゾールの用途別市場規模:2歳以下、2歳以上
・メベンダゾールの北米市場(2016年-2027年)
・メベンダゾールのヨーロッパ市場(2016年-2027年)
・メベンダゾールのアジア太平洋市場(2016年-2027年)
・メベンダゾールの中南米市場(2016年-2027年)
・メベンダゾールの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Johnson & Johnson、Amneal Pharmaceuticals、Cadila Pharmaceuticals、Eipico、Esteve Pharmaceuticals、Tenry
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...
【レポートの概要】

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.

Market Analysis and Insights: Global and China Mebendazole Market
This report focuses on global and China Mebendazole market.
In 2020, the global Mebendazole market size was US$ 111.3 million and it is expected to reach US$ 163 million by the end of 2027, with a CAGR of 5.6% during 2021-2027. In China the Mebendazole market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Mebendazole Scope and Market Size
Mebendazole market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mebendazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Mebendazole market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Tablet
Oral Suspension

Segment by Application
Below 2 Years Old
Above 2 Years Old

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry

【レポートの目次】

1 Study Coverage
1.1 Mebendazole Product Introduction
1.2 Market by Type
1.2.1 Global Mebendazole Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Mebendazole Market Size Growth Rate by Application
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Mebendazole Market Size, Estimates and Forecasts
2.1.1 Global Mebendazole Revenue 2016-2027
2.1.2 Global Mebendazole Sales 2016-2027
2.2 Global Mebendazole, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mebendazole Historical Market Size by Region (2016-2021)
2.3.1 Global Mebendazole Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mebendazole Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mebendazole Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mebendazole Sales Forecast by Region (2022-2027)
2.4.2 Global Mebendazole Revenue Forecast by Region (2022-2027)

3 Global Mebendazole Competitor Landscape by Players
3.1 Global Top Mebendazole Manufacturers by Sales
3.1.1 Global Mebendazole Sales by Manufacturer (2016-2021)
3.1.2 Global Mebendazole Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mebendazole Manufacturers by Revenue
3.2.1 Key Mebendazole Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mebendazole Revenue by Manufacturers (2016-2021)
3.2.3 Global Mebendazole Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mebendazole Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mebendazole Revenue in 2020
3.2.6 Global Mebendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mebendazole Price by Manufacturers
3.4 Global Mebendazole Manufacturing Base Distribution, Product Types
3.4.1 Mebendazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mebendazole Product Type
3.4.3 Date of International Manufacturers Enter into Mebendazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Mebendazole Market Size by Type (2016-2021)
4.1.1 Global Mebendazole Sales by Type (2016-2021)
4.1.2 Global Mebendazole Revenue by Type (2016-2021)
4.1.3 Mebendazole Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mebendazole Market Size Forecast by Type (2022-2027)
4.2.1 Global Mebendazole Sales Forecast by Type (2022-2027)
4.2.2 Global Mebendazole Revenue Forecast by Type (2022-2027)
4.2.3 Mebendazole Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Mebendazole Market Size by Application (2016-2021)
5.1.1 Global Mebendazole Sales by Application (2016-2021)
5.1.2 Global Mebendazole Revenue by Application (2016-2021)
5.1.3 Mebendazole Price by Application (2016-2021)
5.2 Mebendazole Market Size Forecast by Application (2022-2027)
5.2.1 Global Mebendazole Sales Forecast by Application (2022-2027)
5.2.2 Global Mebendazole Revenue Forecast by Application (2022-2027)
5.2.3 Global Mebendazole Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Mebendazole Market Size YoY Growth 2016-2027
6.1.1 China Mebendazole Sales YoY Growth 2016-2027
6.1.2 China Mebendazole Revenue YoY Growth 2016-2027
6.1.3 China Mebendazole Market Share in Global Market 2016-2027
6.2 China Mebendazole Market Size by Players (International and Local Players)
6.2.1 China Top Mebendazole Players by Sales (2016-2021)
6.2.2 China Top Mebendazole Players by Revenue (2016-2021)
6.3 China Mebendazole Historic Market Review by Type (2016-2021)
6.3.1 China Mebendazole Sales Market Share by Type (2016-2021)
6.3.2 China Mebendazole Revenue Market Share by Type (2016-2021)
6.3.3 China Mebendazole Price by Type (2016-2021)
6.4 China Mebendazole Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Mebendazole Sales Forecast by Type (2022-2027)
6.4.2 China Mebendazole Revenue Forecast by Type (2022-2027)
6.4.3 China Mebendazole Price Forecast by Type (2022-2027)
6.5 China Mebendazole Historic Market Review by Application (2016-2021)
6.5.1 China Mebendazole Sales Market Share by Application (2016-2021)
6.5.2 China Mebendazole Revenue Market Share by Application (2016-2021)
6.5.3 China Mebendazole Price by Application (2016-2021)
6.6 China Mebendazole Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Mebendazole Sales Forecast by Application (2022-2027)
6.6.2 China Mebendazole Revenue Forecast by Application (2022-2027)
6.6.3 China Mebendazole Price Forecast by Application (2022-2027)

7 North America
7.1 North America Mebendazole Market Size YoY Growth 2016-2027
7.2 North America Mebendazole Market Facts & Figures by Country
7.2.1 North America Mebendazole Sales by Country (2016-2021)
7.2.2 North America Mebendazole Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Mebendazole Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mebendazole Market Facts & Figures by Region
8.2.1 Asia Pacific Mebendazole Sales by Region (2016-2021)
8.2.2 Asia Pacific Mebendazole Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Mebendazole Market Size YoY Growth 2016-2027
9.2 Europe Mebendazole Market Facts & Figures by Country
9.2.1 Europe Mebendazole Sales by Country (2016-2021)
9.2.2 Europe Mebendazole Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Mebendazole Market Size YoY Growth 2016-2027
10.2 Latin America Mebendazole Market Facts & Figures by Country
10.2.1 Latin America Mebendazole Sales by Country (2016-2021)
10.2.2 Latin America Mebendazole Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Mebendazole Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mebendazole Market Facts & Figures by Country
11.2.1 Middle East and Africa Mebendazole Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mebendazole Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Mebendazole Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Amneal Pharmaceuticals
12.2.1 Amneal Pharmaceuticals Corporation Information
12.2.2 Amneal Pharmaceuticals Description and Business Overview
12.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amneal Pharmaceuticals Mebendazole Products Offered
12.2.5 Amneal Pharmaceuticals Recent Development
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Corporation Information
12.3.2 Cadila Pharmaceuticals Description and Business Overview
12.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cadila Pharmaceuticals Mebendazole Products Offered
12.3.5 Cadila Pharmaceuticals Recent Development
12.4 Eipico
12.4.1 Eipico Corporation Information
12.4.2 Eipico Description and Business Overview
12.4.3 Eipico Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eipico Mebendazole Products Offered
12.4.5 Eipico Recent Development
12.5 Esteve Pharmaceuticals
12.5.1 Esteve Pharmaceuticals Corporation Information
12.5.2 Esteve Pharmaceuticals Description and Business Overview
12.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Esteve Pharmaceuticals Mebendazole Products Offered
12.5.5 Esteve Pharmaceuticals Recent Development
12.6 Tenry
12.6.1 Tenry Corporation Information
12.6.2 Tenry Description and Business Overview
12.6.3 Tenry Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Tenry Mebendazole Products Offered
12.6.5 Tenry Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Mebendazole Products Offered
12.11.5 Johnson & Johnson Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mebendazole Industry Trends
13.2 Mebendazole Market Drivers
13.3 Mebendazole Market Challenges
13.4 Mebendazole Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mebendazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Johnson & Johnson、Amneal Pharmaceuticals、Cadila Pharmaceuticals、Eipico、Esteve Pharmaceuticals、Tenry

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ メベンダゾールのグローバル及び中国市場インサイト・予測(~2027年)(Global and China Mebendazole Market Insights, Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。